Latest filing published 17 May 2017 for Novelion Therapeutics Inc., €2,159.
This profile gathers the share dealings of Jason Aryeh in Novelion Therapeutics Inc. The record holds 11 filings, for trades running from 4 June 2012 to 15 May 2017.
The open-market record is one-sided, with 1 purchase worth €2,159 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2017 alone, the filings show 1 purchase and no sales.
On 17 May 2017 came the latest disclosure, an open-market purchase for €2,159 in Novelion Therapeutics Inc. Typically, a trade is published a median of 11 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations